Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Psychiatry
•
Psychotic Disorders
•
General Psychiatry
How do you approach the use and titration of Cobenfy in patients with treatment refractory schizophrenia not responding to clozapine?
Related Questions
How do you transition patients between different long-acting injectable antipsychotics?
How do you counsel patients on the risks and benefits of antidepressant use during pregnancy?
When would you consider prescribing a wakefulness promoting agent for excessive daytime sleepiness from insufficient sleep?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
What strategies have you found most effective for obtaining prior authorization for newer antipsychotics and antidepressants?
What medications do you find helpful to reduce drooling associated with antipsychotics?
When do you consider using olanzapine/samidorphan?
How have you incorporated long-acting injectables into private practice or other settings that haven’t traditionally offered them?
Other than clozapine, what antipsychotics do you use in a manic or psychotic patient with TD?
Do you consider using buspirone for the management of anxiety in older patients?
